Survodutide 10mg

Survodutide — 10 mg

Dual GLP-1 and glucagon receptor agonist research peptide, studied in preclinical models for metabolic signaling and energy regulation.

Available in France as a lyophilized powder, 10 mg vial, intended exclusively for laboratory research.

Product intended exclusively for laboratory research. Not intended for human or animal consumption.

What is Survodutide?

Survodutide is a research peptide belonging to the class of dual GLP-1/glucagon receptor agonists . It is being studied for its ability, in preclinical models, to interact simultaneously with two molecular targets: the GLP-1 receptor ( an incretin hormone) and the glucagon receptor.

This dual action makes it an object of interest in research on metabolic signaling pathways . It belongs to the broader family of incretin agonist peptides studied in the laboratory, alongside GLP-1 analogues such as semaglutide or triple agonists such as retatrutide.